rs1554084299
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000038.6(APC):c.2612delG(p.Gly871GlufsTer45) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000038.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.2612delG | p.Gly871GlufsTer45 | frameshift_variant | Exon 16 of 16 | 5 | NM_000038.6 | ENSP00000257430.4 | ||
ENSG00000258864 | ENST00000520401.1 | n.228+9234delG | intron_variant | Intron 3 of 7 | 3 | ENSP00000454861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Carcinoma of colon Pathogenic:1
The APC p.Gly871Glufs*45 variant was identified in 2 of 2502 proband chromosomes (frequency: 0.0008) from individuals or families with FAP (Friedl 2005, Gebert 1999). This variant was also reported in a patient with FAP as the causative variant (Mayer 2009). The variant was also identified in ClinVar (1x as pathogenic by Ambry Genetics) and LOVD 3.0 (2x as pathogenic). The variant was not identified in dbSNP, Cosmic, MutDB, UMD-LSDB, databases. The variant was not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.2612del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 871 and leads to a premature stop codon 45 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the APC gene are an established mechanism of disease in familial adenomatous polyposis (FAP) and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.2612delG pathogenic mutation, located in coding exon 15 of the APC gene, results from a deletion of one nucleotide at nucleotide position 2612, causing a translational frameshift with a predicted alternate stop codon (p.G871Efs*45). This mutation has been reported in two individuals with clinical features of familial adenomatous polyposis (Gebert JF et al. Ann. Surg. 1999 Mar;229:350-61; Friedl W et al. Hered. Cancer Clin. Pract. 2005 Sep;3:95-114). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at